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Neutrophils, in response to a chemoattractant gra-
dient, undergo dynamic F-actin remodeling, a
process important for their directional migration or
chemotaxis. However, signaling mechanisms for
chemoattractants to regulate the process are in-
completely understood. Here, we characterized
chemoattractant-activated signaling mechanisms
that regulate cofilin dephosphorylation and actin
cytoskeleton reorganization and are critical for neu-
trophil polarization and chemotaxis. In neutrophils,
chemoattractants induced phosphorylation and inhi-
bition of GSK3 via both PLCb-PKC and PI3Kg-AKT
pathways, leading to the attenuation of GSK3-medi-
ated phosphorylation and inhibition of the cofilin
phosphatase slingshot2 and an increase in dephos-
phorylated, active cofilin. The relative contribution
of this GSK3-mediated pathway to neutrophil che-
motaxis regulation depended on neutrophil polarity
preset by integrin-induced polarization of PIP5K1C.
Therefore, our study characterizes a signaling mech-
anism for chemoattractant-induced actin cytoskel-
eton remodeling and elucidates its context-depen-
dent role in regulating neutrophil polarization and
chemotaxis.
INTRODUCTION
Chemotaxis is a process in which a cell migrates following
a gradient of a chemoattractant and plays an important role in
embryonic development, wound healing, tumor metastasis,
and various aspects of leukocyte biology including leukocyte
infiltration, recruitment, trafficking, and homing. Neutrophils,
a type of leukocytes, are an excellent system for studying the
basic mechanisms underlying chemotaxis. They are the most
motile cells in higher organisms and can efficiently interpret1038 Developmental Cell 21, 1038–1050, December 13, 2011 ª2011and chemotax under a shallow chemoattractant gradient. Circu-
lating neutrophils are nonpolarized. Upon stimulation, they
polarize by forming the leading edge or the ‘‘front’’ that is rich
in lamellar filamentous actin (F-actin) and the uropod (the
‘‘back’’) that is rich in actomyosin filaments. When a chemoat-
tractant gradient is present, the cell can sense and align
its front-back polarity with the chemoattractant gradient and
migrate directionally up the gradient. Therefore, cell polarization
provides a link between the two other basic characteristics of
chemotaxis: directionality (the ability to follow the gradient) and
locomotion (or motility). The questions have been how chemoat-
tractants and their gradients regulate the polarization, direction-
ality, and locomotion.
Chemoattractants regulate a wide range of signaling mole-
cules. Among them, phosphatidylinositol 3,4,5-trisphosphate
(PtdIns (3,4,5)P3) has been at the center of chemotaxis research
for its localization at the leading edges of chemotaxing Dictyos-
telium cells (Parent et al., 1998). This polarization is attributed to
phosphatidylinositol 3-kinase (PI3K) localization at the leading
edge and phosphatase and tensin homolog (PTEN) localization
at the uropods (Funamoto et al., 2002; Iijima and Devreotes,
2002). Polarized PtdIns (3,4,5)P3 localization also occurs in
neutrophils (Servant et al., 2000). Disruption of the PI3K-
PtdIns(3,4,5)P3 pathway may or may not cause significant
defects in neutrophil and Dictyostelium chemotaxis depending
on the experimental contexts. Together with other signaling
pathways being identified for the regulation of Dictyostelium
and neutrophil chemotaxis, it is now believed that chemotaxis
is regulated by multiple signaling pathways (see reviews in
Stephens et al., 2008; Afonso and Parent, 2011). However,
how different signaling pathways interact and contribute to the
regulation of chemotaxis, particularly neutrophil chemotaxis,
has been understudied.
We and others previously showed that chemoattractants
including formyl-Met-Leu-Phe (fMLP) and CXCL2 stimulated
PtdIns(3,4,5)P3 formation via PI3Kg in mouse neutrophils
(Hirsch et al., 2000; Li et al., 2000; Sasaki et al., 2000). One of
the mechanisms by which PI3Kg regulates neutrophil polariza-
tion and directionality is to localize the activation of CDC42
and F-actin formation at the leading edge in accordance to theElsevier Inc.
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A GSK-SSH2 Pathway Regulates Neutrophil Chemotaxischemoattractant gradients (Li et al., 2003). CDC42 belongs to the
Rho family of small GTPases that also include RhoA and Rac
(Ridley, 2001; Etienne-Manneville and Hall, 2002). In neutrophils,
CDC42 regulates the directionality by directing where F-actin
and the leading edge are formed, and Rac promotes F-actin
formation in the leading edge (Gu et al., 2003; Li et al., 2003;
Srinivasan et al., 2003; Szczur et al., 2009). CDC42 and Rac
probably act through the WASP and WAVE complexes. On the
other hand, RhoA regulates the formation and contractility of
the actomyosin structure at the back via regulating the phos-
phorylation of myosin light chain (Xu et al., 2003; Shin et al.,
2010).
The actin-depolymerizing factor (ADF)/cofilin family of actin-
binding proteins plays important roles in actin dynamics and
cell migration (Oser and Condeelis, 2009; Bernstein and Bam-
burg, 2010). Cofilin activity is subjected to various forms of
regulations. Among them, its phosphorylation and binding to
PtdIns(4,5)P2 are the best studied for their role in regulating the
F-actin-severing activity (van Rheenen et al., 2009; Bernstein
and Bamburg, 2010). Cofilin is inactivated by phosphorylation
at Ser3. The LIM (Lin-11/Isl-1/Mec-3) and TES (testicular protein)
kinases phosphorylate, whereas slingshot (SSH) and chronophin
(CIN) phosphatases dephosphorylate, cofilin at this site (Huang
et al., 2006). In neutrophils, chemoattractants induce the de-
phosphorylation of cofilin (van Rheenen et al., 2009), which
appears to depend on Rac (Sun et al., 2007). Because Rac or
the other Rho small GTPases stimulate LIMK/TESKs (Huang
et al., 2006), it is unlikely that chemoattractants or Rac stimulate
cofilin dephosphorylation via regulating these cofilin kinases.
In this study, we identified a signaling mechanism by
which fMLP induces cofilin dephosphorylation via regulating
the cofilin phosphatase SSH2. SSH2 is phosphorylated and
inhibited by the protein kinase GSK3, which is negatively regu-
lated by fMLP. In neutrophils, fMLP suppresses GSK3 activity
by inducing GSK3 phosphorylation through both PLCb-PKC
and PI3Kg-AKT pathways. Moreover, we demonstrated that
this PLCb/PI3Kg-GSK3-SSH2 pathway played a role in polarized
formation of lamellar F-actin at the leading edge and neutrophil
chemotaxis. Furthermore, we investigated the interaction of
this GSK3-mediated front signaling pathway with an integrin-
regulated back signaling mechanism and revealed how the
context may alter the relative significance of this PLC/PI3K
pathway in its regulation of neutrophil chemotaxis.
RESULTS
Both PLCb-PKC and PI3Kg-AKT Signaling Pathways Are
Involved in GSK3 Phosphorylation in Mouse Neutrophils
In our attempt to identify additional PtdIns(3,4,5)P3 effectors
in regulating neutrophil chemotaxis, we examined whether
PI3Kg-deficiency affected the phosphorylation of GSK3a at
Ser21 and GSK3b at Ser9, which are dependent on the PI3K-
PtdIns(3,4,5)P3-Akt signaling axis in many other systems (Down-
ward, 1998). The neutrophil chemoattractant fMLP induced
robust GSK3 phosphorylation at both sites, which peaked
at 3 min (see Figure S1A available online). However, PI3Kg-
deficiency, which abrogated Akt phosphorylation at Ser473 and
Thr308 (Figure 1A) (Hirsch et al., 2000; Li et al., 2000; Sasaki
et al., 2000), merely reduced GSK3 phosphorylation by aroundDevelopmenta20% at 3 min of fMLP treatment, although it caused 60%
reduction at 1 min (Figure 1A). The neutrophils lacking PLCb2/b3
(referred to as PLCb in this article), which were fortuitously
included as a control, also showed reduced GSK3 phosphoryla-
tion compared to the wild-type (WT) cells (Figure 1A). PLCb-
deficiency had little effect on fMLP-induced Akt phosphoryla-
tions (Figure 1A). Because neutrophils lacking PLCb2/b3 and
PI3Kg (referred to as ‘‘triple KO’’) completely failed to responded
to fMLP (Figure 1A) or another neutrophil chemoattractant
CXCL2 (Figure S1B) in GSK3 phosphorylation, we concluded
that both PLCb and PI3Kg pathways were required for GSK3
phosphorylation in mouse neutrophils. This conclusion was
further supported by the observation that the PI3K inhibitor
LY294002 completely abrogated fMLP-induced GSK3 phos-
phorylation in PLCb null neutrophils (Figure S1C).
Consistent with the requirement of PLCb for PKC activation
in mouse neutrophils (Jiang et al., 1997; Li et al., 2000), the
PKC inhibitor Ro 31-8220, which inhibits the classic PKC iso-
forms including PKCa, b, and g, inhibited fMLP-induced GSK3
phosphorylation in WT, but not PLCb-deficient, neutrophils (Fig-
ure S1C). In addition, Ro 31-8220 abrogated GSK3 phosphory-
lation in PI3Kg-deficient neutrophils (Figure 1B). The involvement
of PKC in GSK3 phosphorylation was further corroborated by
the use of phorbol-12-myristate-13-acetate (PMA), a PKC acti-
vator. PMA stimulated the phosphorylation of myristoylated
alanine-rich C-kinase substrate (MARCKS, a known PKC sub-
strate) and GSK3, which could be inhibited by Ro 31-8220, but
not by PLCb-deficiency or LY294002 (Figure 1C). PMA had little
effect on AKT phosphorylation (Figure 1C). Moreover, recombi-
nant PKCa could directly phosphorylate recombinant GSK3b
(Figure 1D). These results, together with the fact that the AKT
inhibitor (VIII) had similar effects as PI3Kg-deficiency on GSK3
phosphorylation (Figure 1E), support a conclusion that both
PKC and AKT are involved in GSK3 phosphorylation.
Localization of PLCb2, PKC Activation, and GSK3
Phosphorylation at the Leading Edge
PtdIns(3,4,5)P3 is localized at leading edges of chemotaxing
neutrophils and Dictyostelium cells. We examined where PLCb2
is localized in chemotaxing neutrophils. Primary mouse neu-
trophils expressing GFP-PLCb2 and a red fluorescent protein
tdTomato were stimulated by an fMLP gradient from a micropi-
pette. The localization of GFP-PLCb2 appeared to be skewed
toward the leading edges of chemotaxing neutrophils because
the ratios of PLCb2-GFP to tdTomato became significantly
higher at the leading edges than those at the uropods after
a few of minutes of stimulation (Figures 2A and 2B; Figure S2A;
Movie S1A). PLCb2 interacts with and is activated by heterotri-
meric G proteins (the Gbg subunits as well as the a subunits of
the Gq family) and the small GTPases including Rac (Harden
and Sondek, 2006). Rac shows highly polarized localization at
the leading edges of chemotaxing neutrophils (Gu et al., 2003;
Srinivasan et al., 2003). Thus, the interaction between Rac
and PLCb2 may have a role in the leading edge localization of
PLCb2. To test the idea, we transfected neutrophils with plas-
mids encoding tdTomato and aPLCb2mutant with a substitution
of Ala for Gln52 (Q52A). This mutation greatly weakens the inter-
action of PLCb2 with Rac (Jezyk et al., 2006; Hicks et al., 2008)
and rendered the PLC-b2 mutant unable to exhibit a polarizedl Cell 21, 1038–1050, December 13, 2011 ª2011 Elsevier Inc. 1039
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Figure 1. PLCb-PKC and PI3Kg-AKT Regulate GSK3 Phosphorylation in Mouse Neutrophils
(A) Requirement of PLCb and PI3Kg signaling for fMLP-induced GSK3 phosphorylation. Neutrophils from WT, PLCb2/b3 (Plc), PI3Kg (Pi3k), or PLCb2/b3;PI3Kg
(Tri)-deficient mice were stimulated with fMLP for indicated duration. Data are shown as mean ± SEM (*p < 0.05 versus corresponding WT controls; ns, p > 0.1;
Student’s t test). See also Figures S1A and S1B.
(B and E) Pharmacological inhibition of PKC and AKT. WT and mutant neutrophils were pretreated with vehicle control (Vc), Ro 31-8220 (Ro), or the AKT inhibitor
VIII, followed by stimulation with fMLP for indicated durations. Data quantified from four experiments are shown as mean ± SEM (*p < 0.01; Student’s t test). See
also Figure S1C.
(C) Stimulation of GSK3 phosphorylation by PMA. Neutrophils were pretreated with LY294002 (LY) or Ro 31-8220 (Ro) for 30min before stimulation by PMA (1 mM,
8 min).
(D) Phosphorylation of GSK3b by PKCa and AKT1 in an in vitro kinase assay.
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A GSK-SSH2 Pathway Regulates Neutrophil Chemotaxisdistribution in chemotaxing neutrophils (Figures 2A and 2B; Fig-
ure S2B; Movie S1B). This result indicates that PLCb2’s interac-
tion with Rac is critical for its polarized localization at the leading
edge.1040 Developmental Cell 21, 1038–1050, December 13, 2011 ª2011We next investigated where PKC is activated using an intra-
molecular FRET (fluorescence resonance energy transfer) probe
that has been previously demonstrated to be specific for PKC
activation (Violin et al., 2003). There were significantly greaterElsevier Inc.
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Figure 2. Localization of PLCb2, PKC Activation, and Phosphorylated GSK3 in Neutrophils
(A and B) Leading edge localization of PLCb2. WT neutrophils expressing tdTomato and PLCb2-GFP or tdTomato and PLCb2-Q52A-GFP were stimulated by an
fMLP gradient from a micropipette. Images were recorded at 30 s intervals, and ratio (GFP/Tomato) images of representative cells are shown. (A) The asterisks
denote the direction of the micropipette placement. The ratios of front GFP/Tomato ratios to back GFP/Tomato ratios (boxed areas) are plotted in (B). Data are
shown as mean ± SEM (*p < 0.05 versus time 0; n = 5, Student’s t test). See also Figures S2A and S2B and Movies S1 and S2.
(C–E) Activation of PKC at the leading edge. WT or PLCb-deficient neutrophils expressing the FRET probe for PKC activity were stimulated with fMLP from
a micropipette. Emission (CFP/FRET) ratio images of representative cells are shown (C). Normalized CFP/FRET ratios of the recorded cells (D) and ratios of the
front emission ratios to the back (boxed areas, E) are plotted. Data are shown as mean ± SEM (*p < 0.05 versus time 0; n = 5, Student’s t test). See also Figures
S2C and S2D.
(F) Localization of phosphorylated GSK3. WT and triple KO neutrophils were stimulated with fMLP, fixed, and immunostained with a phospho-GSK3 antibody
(green) and Alexa Fluor 633-phalloidin (red). The cells were examined using a confocal microscope.
The scale bars are 4 mm.
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A GSK-SSH2 Pathway Regulates Neutrophil Chemotaxisincreases in the ratios of 490:530 nm emission (Em490/530),
which reflects an increase in PKC kinase activity, upon fMLP
stimulation in WT cells than the PLCb null cells (Figures 2C
and 2D; Figure S2C; Movie S2A). Importantly, there were greater
increases in the Em490/530 ratios at the leading edges than
those at the uropods when the cells chemotaxed (Figure 2E).
Such increases were absent in PLCb null neutrophils (Figures
2C and 2E; Figure S2D; Movie S2B), indicating that the changes
observed in the WT cells depend on PLCb. Consistent with the
localization of PKC activation, elevated levels of phosphorylated
GSK3 were detected at the leading edges of polarized WT
neutrophils by immunostaining (Figure 2F). The triple KO neu-
trophils, in which no phosphorylated GSK3 was detected by
western analysis (Figure 1A), were used as a negative control
for immunostaining (Figure 2F). Thus, we concluded that PLCb,
which is localized to the leading edge in a Rac-dependent
manner, stimulated the PKC activity and GSK3 phosphorylation
at the leading edge.
Compounded Effect of PLCb and PI3Kg Signaling
on Neutrophil Migration
Knowing that the PLCb and PI3Kg signaling is polarized at the
leading edge and regulates GSK3 phosphorylation, we wanted
to determine their roles in neutrophil chemotaxis. Neutrophils
lacking PLCb2/b3 have been previously examined in a transwell
chemotaxis assay, in which the PLC mutant cells showed little
defects in response to fMLP or Interleukin 8 (a human ortholog
of CXCL2) (Jiang et al., 1997). Neutrophils lacking PI3Kg have
also been evaluated in a number of different chemotaxis assays,
and the results varied (discussed in the ‘‘Introduction’’). The vari-
ations may partly be attributed to different surfaces used in the
assays, given that integrin signaling had a significant impact on
neutrophil polarization (Ferguson et al., 2007; Xu et al., 2010).
Therefore, we here examined neutrophil chemotaxis on surfaces
coated with poly-lysine, which minimizes integrin signaling,
or fibrinogen, which maximizes integrin signaling, in a Dunn
chamber assay. We have also introduced some modifications
into the Dunn chamber assay as recently described (Xu et al.,
2010; Zhang et al., 2010). In this modified assay, the WT and
mutant cells were labeled with a yellow cell-tracing dye alter-
nately and assayed simultaneously, and the fMLP gradients
were monitored with the FITC dye that diffuses similarly as
fMLP. These modifications help to improve reproducibility and
sensitivity of the assay. Using this improved Dunn chamber
assay, we found that deficiency in PLCb, PI3Kg, or both PLCb
and PI3Kg did not significantly affect the number of motile
neutrophils (Figures S3A–S3E) or motility (Figure S3F) on the
poly-lysine surfaces. However, these mutant cells show one
mild chemotactic defect. They had greater average directional
errors than the WT cells with the triple KO cells showing the
greatest errors (Figure S3G), suggesting that these mutant cells
did not follow the fMLP gradient as well as the WT cells.
When these neutrophils were tested on the fibrinogen surface,
the triple KO cells showed a severe chemotactic defect (Figures
S3H and S3I). Approximately 40% of the triple KO neutrophils
failed to chemotax in response to fMLP (Figure 3A) or CXCL2
(Figure 3B). However, the responding cells chemotaxed as fast
as theWT cells (Figure 3C), despite with greater directional errors
than these cells (Figure 3D). A previous report had shown that1042 Developmental Cell 21, 1038–1050, December 13, 2011 ª2011PI3Kg-deficiency reduced the number chemotaxing neutrophils
on fibrinogen (Ferguson et al., 2007). Although in our assay
PI3Kg-deficiency did not cause statistically significant reduction
in the chemotaxing cells, there appeared to be a trend for such
a reduction (Figure 3A). Together with the lack of a significant
effect of PLCb-deficiency on the number of chemotaxing cells
(Figure 3A), we concluded that there was a significant com-
pounded effect on neutrophil chemotactic responses on the
fibrinogen surface when both PLCb and PI3Kg are depleted.
Because fMLP and CXCL2 stimulate GSK3 phosphorylation
and inhibit its activity through PLCb and PI3Kg in neutrophils,
we tested if pharmacological inhibition of GSK3 would rescue
some of the chemotactic defects of the triple KO cells. Although
the GSK3 inhibitor SB216763 did not significantly affect the
number of theWT cells (Figure 3A) or themotility of WT or mutant
cells (Figure 3C), it reversed the immotile phenotype of the
mutant cells (Figure 3A) in response to fMLP, despite that the
mutant cells still had a greater directional error than the WT cells
(Figure 3D). This incomplete rescue may be due to the incom-
plete action of the GSK inhibitor or other signaling pathways
such as the regulation of PIXa by PI3Kg (Li et al., 2003).
SB216763 was also able to reverse the immotile phenotype in
response to CXCL2 (Figure 3B). In addition, another GSK3 inhib-
itor LiCl2 showed similar effects as SB216763 (data not shown).
Therefore, we conclude that GSK3 is involved in PLCb and
PI3Kg-mediated regulation of neutrophil chemotaxis.
PI3K and PLC-b Signaling Regulates F-Actin
Polarization in Neutrophils
We next wanted to understand why some of the triple KO cells
failed to respond to chemoattractants to chemotax. Polarized
formation of F-actin upon chemoattractant stimulation plays an
important role in chemotaxis.We examined the effect of the triple
deficiency on fMLP-induced F-actin polarization. We found that
some of the triple KO neutrophils showed broader, less polarized
distribution of F-actin staining than the WT cells (Figure 3E) after
a quick stimulation by a uniform fMLP. To quantify this differ-
ence, we defined a cell with lamellar F-actin staining at the
periphery occupying less than 50% of the circumference of the
cell as being polarized, as described previously (Ferguson
et al., 2007) and illustrated in Figure 3E. Fewer of the triple KO
neutrophils were ‘‘polarized’’ than the WT cells based on this
criterion (Figure 3F). The number of PLCb or PI3Kg null neutro-
phils exhibiting polarized F-actin was between these of WT
and the triple KO (Figure 3F). Importantly, GSK3 inhibitors were
able to significantly increase the number of polarized triple KO
cells (Figure 3F). These results suggest that PLCb/PI3Kg sig-
naling may regulate actin cytoskeleton reorganization during
leading edge formation through their regulation of GSK3.
The Significance of the PLCb/PI3K-Mediated Front
Signaling in Chemotaxis Depends on Integrin-Induced
Back Signaling
We were intrigued by the dichotomic behaviors of the triple KO
neutrophils on fibrinogen, i.e., close to one-half of the cells failed
to migrate, whereas the rest could chemotax almost normally.
Fibrinogen can engages integrins, which can induce polarized
localization of PIP5K1C independently of exogenous chemoat-
tractants to specify the initial location of the uropod formedElsevier Inc.
50
70
90
110
M
ot
ile
 C
el
ls
 (%
) *
WT Plc Pi3k Tri
A B
WT Tri
Vc
SB
0.0
0.5
1.0
1.5
M
ot
ilit
y 
(μ
m
/m
in
)
WT Plc Pi3k Tri WT Tri
Vc
SB
C
40
50
60
70
80
90
D
ire
ct
io
na
l
Er
ro
r (
de
gr
ee
)
WT Plc Pi3k Tri WT Tri
Vc
SB*
*
*
*
*
*
*
E
WT * Tri 20
40
60
80
100
Po
la
riz
at
io
n 
(%
) *
*
*F
*
*
*
WT Plc Pi3k Tri WT
+SB
Tri
+SB
Tri
+Li
WT
+Li
D
50
60
70
80
90
100
110
WT Tri
M
ot
ile
 C
el
ls
 (%
) *
Vc
SB
fMLP
fMLP fMLP
CXCL2
Figure 3. PLCb/PI3Kg Signaling Regulates Neutrophil Chemotaxis and F-Actin Polarization
(A–D) Roles of PLCb/PI3Kg signaling in neutrophil chemotaxis on fibrinogen. Chemotaxis ofWT andmutant neutrophils pretreatedwith Vc or SB216763 for 15min
was assessed in a Dunn chamber coated with fibrinogen (100 mg/ml) in response to fMLP (A, C, and D) or CXCL12 (B). Percentage of chemotaxing cells relative
to WT (85%–90% of WT cells were motile in all of these experiments, A and B), motility (C), and average directional errors (D) are presented as mean ± SEM
(*p < 0.05; Student’s t test). See also Figure S2.
(E and F) Roles of PLCb/PI3K signaling on F-actin polarization. Neutrophils were stimulated with fMLP and stainedwith Alexa Fluor 633-phalloidin. Representative
images of WT or triple KO cells are shown in (E). Asterisks indicate cells considered as being polarized in their F-actin distributions. The numbers of cells showing
polarized F-actin distribution were quantified from three experiments (more than 50 cells were counted for each condition, F). Data are presented asmean ± SEM
(*p < 0.05; Student’s t test).
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A GSK-SSH2 Pathway Regulates Neutrophil Chemotaxisupon chemoattractant stimulation (Xu et al., 2010). Given that
neutrophils in the Dunn chamber assay were placed on fibrin-
ogen prior to chemoattractant stimulation, a significant portion
of cells might have their polarity preset by integrin signaling as
we previously demonstrated (Xu et al., 2010). Thus, we hypoth-
esized that cells with their preset polarity being aligned against
the direction of a chemoattractant gradient might be more
dependent on PLCb/PI3Kg signaling than those aligned with
the gradient to achieve effective F-actin polarization for cell loco-
motion. To test the hypothesis, we coexpressed GFP-PIP5K1C
and Ruby-LifeAct in WT or the triple KO neutrophils. Ruby-
LifeAct, a probe with a high affinity for polymerized actin (Riedl
et al., 2008), was used to mark the F-actin polarization, whereas
GFP-PIP5K1C was used to mark the preset polarity by integrin
signaling. The cells were placed on fibrinogen to elicit integrin
signaling, followed by directional stimulation of fMLP from a
micropipette that was placed proximally or distally to polarized
GFP-PIP5K1C. Similar to what we showed previously (Xu et al.,
2010), a majority of the WT cells (nine out of ten) responded, as
the one shown in Figure 4A, to form singular F-actin-rich leadingDevelopmentaedges toward the micropipettes when the micropipette was
placed distally to polarized GFP-PIP5K1C, i.e., cells were stimu-
lated by fMLP gradients aligned with the preset polarity. When
the micropipette was placed proximally to polarized GFP-
PIP5K1C, most of the WT cells (eight of ten) were able to even-
tually form their leading edges toward the micropipette even
though Ruby-LifeAct or F-actin initially was polarized away
from the micropipette (Figure 4B).
Eight of ten triple KO neutrophils coexpressing GFP-PIP5K1C
and Ruby-LifeAct behaved like the WT cells when they were
stimulated distally to GFP-PIP5K1C (Figure 4C; Movie S3). How-
ever, a majority of the triple KO cells (nine out of ten), when they
were stimulated proximally to GFP-PIP5K1C, behaved like the
one shown in Figure 4D and Movie S4 and were unable to
polarize or chemotax. These cells were not dead, and they often
formed more than one F-actin-rich pseudopod, which frequently
pointed at different directions as the cell shown in Figure 4D. We
then subjected the immotile cells to the treatment of the GSK3
inhibitor LiCl2 (we were unable to use SB216763 in this case
due to its high autofluorescence), which enabled six of the ninel Cell 21, 1038–1050, December 13, 2011 ª2011 Elsevier Inc. 1043
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Figure 4. Significance of PLCb/PI3K Signaling in the Regulation of Chemotaxis Depends on the Polarity Preset by Integrin-Induced PIP5K1C
Polarization
WT (A and B) or triple KO (C–E) neutrophils expressing Ruby-LifeAct and GFP-PIP5K1C were placed on fibrinogen and stimulated by fMLP from a micropipette
that was placed distally (A and C) or proximally (B, D, and E) to polarized RFP-PIP5K1C-90. Asterisks denote the direction of the pipette placement. Images were
recorded at 30 s intervals, and the fMLPwas applied at 15 s. After 5min of fMLP stimulation, LiCl was added to the cell in (D), and the recording was continued (E).
The scale bars are 4 mm. See also Figure S4 and Movies S3, S4, and S5.
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A GSK-SSH2 Pathway Regulates Neutrophil Chemotaxisimmotile cells to polarize their F-actin to form leading edges and
chemotax. Three out of these six cells as the one shown in Fig-
ure 4E andMovie S5were able to eventually polarize andmigrate
toward the pipette. PLCb or PI3Kg null neutrophils behaved simi-
larly to the WT cells in this test (Figures S4A–S4D). We also
examined cells placed on poly-lysine in which PIP5K1C was
not polarized prior to fMLP stimulation. FMLP induced F-actin
and PIP5K1C polarization in WT and triple KO cells (four cells
out of each genotype; one representative is shown in Figure S4E).
Therefore, these results together indicate that the PLCb/PI3K-
GSK3 pathway plays a role in F-actin polarization and leading
edge formation. In addition, these results also indicate that the
significance of this PLCb/PI3K-GSK pathway in regulating neu-
trophil chemotaxis depends on the integrin-induced polarization
signal.
GSK3 Regulates Cofilin Phosphorylation
Knowing that GSK3 plays a role in regulation of actin cytoskel-
eton reorganization, the next question is how GSK3 regulates
the reorganization. GSK3 is constitutively active, and phosphor-
ylation at Ser9 of GSK3b or Ser21 of GSK3a upon chemoattrac-1044 Developmental Cell 21, 1038–1050, December 13, 2011 ª2011tant stimulation leads to suppression of their kinase activity.
Therefore, we hypothesized that potential GSK3 downstream
targets should be hyperphosphorylated in the absence of
a GSK3 inhibitor and may become hypophosphorylated in its
presence. Thus, we prepared a set of neutrophil cell extracts
from cells treated with or without SB216763. The samples
were digested, labeled with the iTRAQ tags, enriched for phos-
phorylated peptides by TiO2-affinity chromatography, and sub-
jected to LC-MS/MS and quantitative proteomic analysis. We
found that phosphorylation of cofilin at Ser3 was reduced by
SB216763 treatment (Figure S5A). We subsequently confirmed
the change in cofilin Ser3 phosphorylation using a phosphospe-
cific antibody. SB216763, LiCl (Figure 5A), fMLP (Figure 5B),
or CXCL2 (Figure S5B) suppressed cofilin phosphorylation in
neutrophils. In addition, PLCb- or PI3Kg-deficiency reduced,
whereas the triple deficiency almost completely abrogated,
fMLP-induced inhibition of cofilin phosphorylation (Figure 5B).
Moreover, the AKT inhibitor VIII was able to abrogate fMLP-
induced dephosphorylation of cofilin in PLCb null neutrophils
(Figure S5C), further corroborating the conclusion that both
PI3Kg-AKT and PLCb pathways are responsible for cofilinElsevier Inc.
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Figure 5. Regulation of Cofilin Phosphoryla-
tion by the PLCb/PI3Kg-GSK3 Pathway
(A) Pharmacological inhibition of GSK3 reduces
phosphorylated cofilin contents in WT neutrophils.
Data are presented as mean ± SEM (*p < 0.01;
Student’s t test). See also Figure S5A.
(B) Effects of PLCb, PI3Kg , or PLCb/PI3Kg-defi-
ciencyon fMLP-inducedcofilindephosphorylation.
Data are presented asmean ± SEM (*p < 0.01; #p <
0.05; Student’s t test). See also Figures S5B–S5F.
(C) GSK3 expression stimulates cofilin phosphor-
ylation. HEK293 cells were cotransfected with
Myc-tagged cofilin and LacZ (Lz), constitutively
active GSK3b (SA), or kinase-dead GSK3b (KM).
Cells were analyzed by western 24 hr after trans-
fection. Data are presented as mean ± SEM
(*p < 0.01; Student’s t test).
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A GSK-SSH2 Pathway Regulates Neutrophil Chemotaxisdephosphorylation. Furthermore, overexpression of an active
GSK3b containing a substitution of Ser9 for Ala, but not the
kinase dead mutant, in HEK293T cells could induce cofilin phos-
phorylation at Ser3 (Figure 5C). These results demonstrate that
fMLP may regulate cofilin phosphorylation via PLCb/PI3Kg-
regulated GSK3.
We also examined the localization of cofilin and phosphory-
lated cofilin in neutrophils after fMLP stimulation using specific
antibodies. We detected increased cofilin staining at the leading
edges of the WT cells, but not the triple KO cells (Figures S5D
and S5E). Because phosphorylated cofilin appeared to be
distributed evenly in both WT and triple KO cells (Figure S5F),
the elevated total cofilin staining at the leading edges of the
WT cells may largely be composed of unphosphorylated cofilin.
GSK3 Regulates SSH2
To elucidate the mechanism for GSK3 to regulate cofilin phos-
phorylation, we first tested if GSK3 could directly phosphorylate
cofilin. Recombinant cofilin proteinwasprepared fromabacterial
expression system and used in an in vitro kinase assay with
recombinant GSK3b. No phosphorylation of cofilin was detected
(Figure S6A). However, recombinant GSK3b readily phosphory-
lated immunoprecipitated full-length cofilin phosphatase SSH2
or a recombinant SSH2 fragment encompassing the N-terminal
460 amino acids (Figures S6B and S6C). SSH2 was so chosen
because its mRNA content is more than ten times higher than
that of SSH1, SSH3, or chronophin based on our quantitative
gene expression analysis (data not shown). In addition, expres-
sion of GSK3b, but not its kinase dead mutant, was able to
inhibit SSH2-mediated dephosphorylation of cofilin (Figure S6D).
These results together indicate that GSK3b is capable of phos-
phorylating SSH2 and regulating its phosphatase activity.
Bioinformatic analyses using the Scansite predicted that the
N-terminal 124 amino acids of SSH2 contain multiple potential
GSK3 phosphorylation sites. We generated an SSH2 mutant
lacking these 124 amino acids (SSH2DN, Figure S6E). Although
this mutant was capable of dephosphorylating cofilin as effi-
ciently as the WT SSH2 (compare lanes 3 and 5 of Figure 6A),
GSK3b failed to inhibit SSH2DN-mediated dephosphorylation
of cofilin (Figure 6A), suggesting that this N-terminal SSH2
sequence may harbor the GSK3 phosphorylation sites for
GSK3 to regulate the SSH2 activity. We subsequently generated
additional N-terminal deletion mutants (Figure S6E) and foundDevelopmentathat deletion of the first 40 amino acids, but not the first 17 amino
acids, disabled the regulation of the phosphatase activity by
GSK3b (Figure 6A). Hence, this narrowed the possible GSK3
regulation sites on SSH2 down to residues 18–40. We then
generated a number of point mutations. Single substitution for
Ser21 or Ser32 or double substitution for Ser21/Ser25 or Ser32/
Ser35 for Ala had little or weak effects on GSK3-mediated regu-
lation of SSH2 phosphatase activity (Figure 6B; Figure S6F).
However, substitution for all of these four Ser residues resulted
in a mutant (SSH2-S4A) that could not be inhibited by GSK3b
in the cofilin dephosphorylation assay (Figure 6B). Consistent
with these results, SSH2-S4A was not phosphorylated by
GSK3b in an in vitro kinase assay (Figure S6G). Moreover, muta-
tion of these four Ser residues to Glu attenuated the phospha-
tase activity of SSH2 (Figure S6H). All of these results are con-
sistent with the conclusion that GSK3 suppresses the cofilin
phosphatase activity of SSH2 through phosphorylation of these
Ser residues at the N terminus of SSH2.
To determine if SSH2 is phosphorylated at any of these four
residues in neutrophils, we generated phosphospecific anti-
bodies andwere able to obtain two that can recognize phosphor-
ylated Ser21 and Ser32, respectively. In a validation experiment,
the antibody specific for pSer21 was able to detect a band in
HEK293T cells expressing the WT SSH2, but not the Ser21-Ala
mutant, whereas the antibody specific for pSer32 detected the
WT SSH2, but not the Ser32-Ala mutant (Figure S6I). Additionally,
coexpression of WT GSK3b, but not its kinase dead mutant,
increased the signals (Figure S6I), whereas GSK3 inhibitors
reduced the signals (Figure S6J), confirming that phosphoryla-
tion of SSH2 at Ser21 and Ser35 depends on GSK3 in these cells.
We detected endogenous SSH2 proteins using these two phos-
phospecific antibodies. The antibody for pSer21 was unable to
detect endogenous protein, but the antibody for pSer32 was
able to detect a band, which could be suppressed by an SSH2
shRNA (Figure 6C). Importantly, fMLP treatment was able to
reduce the signals detected by the antibody in the WT neutro-
phils, but not in the triple KO neutrophils (Figure 6C).
SSH2 Regulates Cofilin Phosphorylation, Leading Edge
Formation, and Chemotactic Directionality in Mouse
Neutrophils
To further corroborate our conclusion that the PLCb/PI3K-GSK3
signaling pathway regulates neutrophil chemotaxis via itsl Cell 21, 1038–1050, December 13, 2011 ª2011 Elsevier Inc. 1045
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Figure 6. The PLCb/PI3Kg-GSK3 Pathway Regulates SSH2
(A and B) GSK3-mediated inhibition of SSH2 depends on SSH2 N-terminal Ser residues. HEK293 cells were cotransfected with Myc-cofilin, WT GSK3 (GSK),
kinase-dead GSK3 (KM), WT SSH2 (WT), or its mutants (DN, D17, and D40 are deletion of N-terminal 125, 17, and 40 amino acids, respectively; S21, Ser21 to
Ala; S32, Ser32 to Ala; S4A, quadruple mutation of Ser21, Ser25, Ser32 and Ser36 to Ala). See also Figure S6.
(C) PLCb and PI3Kg are involved in fMLP-induced dephosphorylation of SSH2 in neutrophils. Neutrophils were stimulated with fMLP for 3min. Endogenous SSH2
phosphorylation was detected by anti-phospho-SSH2-Ser32 antibody. WT and SSH2-knockdown (sh) neutrophil samples were included to indicate the
endogenous bands of SSH2.
Immunoblots were quantified from three independent experiments, and data are shown as mean ± SEM (*p < 0.01; ns, p > 0.1; Student’s t test).
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neutrophil polarization and chemotaxis. We used the method
we reported recently (Zhang et al., 2010) to express an SSH2-
specific shRNA in primary mouse neutrophils and achieved effi-
cient knockdown of the SSH2 protein contents (Figure 7A).
Expression of the Ssh2 shRNA also impaired fMLP-induced
dephosphorylation of cofilin (Figure 7A), suggesting that SSH2
plays a significant role in regulating cofilin phosphorylation in
mouse neutrophils.
We then examined the effect of SSH2 knockdown on F-actin
polarization. Because cells expressing the Ssh2 shRNA also ex-
pressed YFP, we were able to compare WT and SSH2 shRNA-
expressing cells simultaneously (Figure 7B). Expression of the
SSH2 shRNA (Figure 7C) resulted in a significant reduction in
the number of polarized cells. Expression of YFP alone did not
affect the number of polarized cells (Figures S7A and S7B).
Treatment with SB216763, which could reverse the effect of
the triple deficiency on F-actin polarization (Figure 3F), did not1046 Developmental Cell 21, 1038–1050, December 13, 2011 ª2011reverse the effect of SSH2 knockdown (Figures S6C and S6D),
suggesting that SB216763 acted specifically between PLCb/
PI3Kg and SSH2. In addition, the cells expressing the SSH2
shRNA reduced the number of chemotaxing cells on fibrinogen
in the Dunn chamber assay (Figure 7D). We also examined the
neutrophil expressing an Ssh2 shRNA targeting a different
Ssh2 sequence (Figures S7E–S7G). Thus, these Ssh2 shRNA-
expressing neutrophils behaved similarly to the triple KO cells
in which GSK3 regulation was compromised, which supports
the conclusion that fMLP may regulate polarized F-actin for-
mation and F-actin remodeling via a PLCb/PI3K-GSK3-SSH2-
cofilin pathway in mouse neutrophils, as depicted in Figure 7E.
DISCUSSION
Previous studies have shown that chemoattractants including
fMLP induced cofilin dephosphorylation (Suzuki et al., 1995;
Okada et al., 1996; Heyworth et al., 1997), which may involveElsevier Inc.
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Figure 7. SSH2 Regulates Neutrophil F-Actin Polarization and
Chemotaxis
(A) SSH2 has a significant role in fMLP-induced cofilin dephosphorylation. WT
or SSH2-knockdown (sh) neutrophils were stimulated with fMLP. Immunoblots
were quantified from three independent experiments, and data are shown as
mean ± SEM (*p < 0.01; Student’s t test).
(B and C) SSH2 has a significant role in F-actin polarization. WT and SSH2-
knockdown neutrophils were uniformly stimulated with fMLP for 2 min and
stained with Alexa Fluor 633-phalloidin. YFP-positive cells (green) are SSH2-
knockdown neutrophils. The percentages of cells showing F-actin polarization
are shown in (C) (total of 136 cells were examined in four separate experi-
ments). The scale bar is 4 mm. Data are presented as mean ± SEM (*p < 0.05;
Student’s t test).
(D) SSH2 has a significant role in neutrophil chemotaxis. Chemotaxis of YFP-
positive SSH2-knockdown cells and YFP-negative WT cells was evaluated
using a Dunn chamber coated with fibrinogen. Data are presented as mean ±
SEM (*p < 0.05; Student’s t test). See also Figure S7.
(E) A model describes the regulation of actin cytoskeleton reorganization by
signaling pathways investigated in this study. Both PLCb and PI3Kg signaling
pathways regulate GSK3 phosphorylation, which suppresses GSK3 kinase
activity and relieves GSK3-mediated inhibition of SSH2, leading to cofilin
dephosphorylation. Although Rac is a key regulator for stimulating actin
polymerization, it may also contribute to SSH2 regulation via its regulation
of PLCb.
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Our present study revealed how fMLP, via PLCb and PI3Kg,
regulates cofilin dephosphorylation. Our finding that SSH2 is
negatively regulated by phosphorylation by GSK3, a constitu-Developmentatively active kinase, is consistent with a previous study showing
that dephosphorylation of SSH by a nonspecific l-phosphatase
could boost its phosphatase activity (Soosairajah et al., 2005).
This GSK3-mediated SSH regulation mechanism may occur in
cells beyond neutrophils because PI3K inhibitors can abrogate
SSH activation and cofilin dephosphorylation in response to
growth factors in cells where the PI3K-AKT pathway is the
primary mechanism for phosphorylating GSK3 (Bamburg and
Wiggan, 2002; Nishita et al., 2004).
GSK3 has been established for its role in regulation of cell
polarity in adherent cells by regulating both microtubule
dynamics and organization (Etienne-Manneville and Hall, 2003;
Buttrick and Wakefield, 2008). GSK3 was also recently shown
to play an important role in Dictyostelium polarization, despite
that it is regulated differently in Dictyostelium cells from mam-
malian cells (Kim et al., 2011). Our results in this study have
extended the role of GSK3 to the regulation of actin cytoskeleton
reorganization. Because microtubules do not appear to play
a critical role in rapid neutrophil migration (Xu et al., 2007), the
regulation of neutrophil migration by GSK3 may primarily lie in
its regulation of SSH2 and cofilin phosphorylation.
There is a growing appreciation for the complexity of chemo-
taxis regulation. Chemoattractants induce polarization of neu-
trophils into lamellar F-actin-rich leading edges and contractile
actomyosin-containing uropods. Thus, chemoattractants in-
duce dynamic actin cytoskeleton remodeling involving both
actin polymerization and depolymerization to form these dif-
ferent types of actin structures with spatial and temporal speci-
fications needed for directional cell migration. Polarized dephos-
phorylation of cofilin, which depends on both PI3K and PLC in
mouse neutrophils, may facilitate polarized formation of lamellar
F-actin in the leading edge by severing long actin filaments and
generating barbed ends. Cofilin dephosphorylation is regulated
by signaling mechanisms more than this PLC/PI3K-GSK3 path-
way. In neutrophils, RAC, a key regulator for F-actin formation in
neutrophils, also regulates cofilin dephosphorylation (Sun et al.,
2007). Because RAC regulates both PLCb activity (Hicks et al.,
2008) and localization (Figures 2A and 2B), its regulation of cofilin
dephosphorylation may be partially mediated by PLCb. RAC
may also regulate SSH activity via its stimulation of F-actin
formation because F-actin stimulates SSH activity. This kind of
signaling crosstalk and redundancy occurs not only in SSH
and cofilin dephosphorylation regulation, but also at other
levels of signaling cascades. For instance, GSK3 is regulated
by the PLC and PI3K pathways, whereas PI3K can also localize
CDC42 activation and nucleation of F-actin formation in neutro-
phils. In addition to the crosstalk and redundancy, our results
also suggest that the relative significance of one signaling
pathway may be context dependent or depend on the activity
of the other signaling pathways in a cell. Specifically, the signif-
icance of the PI3Kg/PLCb pathway in neutrophil chemotaxis
depends on the polarity preset by integrin signaling, which con-
fers neutrophil polarity by polarizing the localization of PIP5K1C
and specifying the location of uropods (Xu et al., 2010). The
establishment of uropods at one side of a cell induced by integrin
signaling may compel the formation of the leading edge at the
other side of the cell. If the preset polarity of a cell aligns with
the chemoattractant gradient, it would move following the
preset polarity, and the PLCb/PI3K pathway appears to be lessl Cell 21, 1038–1050, December 13, 2011 ª2011 Elsevier Inc. 1047
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aligns against the chemoattractant gradient, the cell may have to
rely on these chemoattractant-activated signaling pathways to
redirect F-actin formation and turn around. We believe that
the crosstalk/redundancy and context dependency of these
signaling pathways may help to understand the variable chemo-
tactic phenotypes reported for disruption of some of the sig-
naling pathways, including the PI3K pathway (Stephens et al.,
2008; Afonso and Parent, 2011).
The involvement of PLCb in cofilin dephosphorylation as re-
vealed by this study may have another advantage. PtdIns(4,5)
P2 binds to dephosphorylated cofilin and inhibits its F-actin-
severing activity. Thus, PLC activation may not only lead to
dephosphorylation of cofilin but also to a possible reduction
in PtdIns(4,5)P2 contents, which would ensure a full activation
of cofilin. Although chemoattractants may only induce transit
global reduction in PtdIns(4,5)P2 contents (Stephens et al.,
1993), it is possible that chemoattractantsmay induce a localized
reduction. This possibility will be investigated in future studies.
EXPERIMENTAL PROCEDURES
Reagents and Constructs
The WT mouse SSH2 expression plasmid and antibody for mouse SSH2 were
kindly provided by Tadashi Uemura (Kyoto University, Japan) (Ohta et al.,
2003). The GFP-PLC-b2 plasmid was described previously (Hicks et al.,
2008). Ruby-LifeAct plasmid is a generous gift from Wedlich-Soldner (Riedl
et al., 2008). Plasmid encoding the PKC activity FRET probe, CKAR, was previ-
ously described (Violin et al., 2003) and obtained from Addgene. The anti-
bodies specific for phospho-Ser21 and Ser32 of mouse SSH2 were generated
at AbMax (Beijing, China). The SSH2, GSK3, and PLC-b2 mutant plasmids
were generated by PCR-based mutagenesis and verified by nucleotide
sequencing. The phospho-Ser3-cofilin, cofilin, phospho-GSK3, phospho-
Ser473-AKT, phospho-Thr308-AKT, AKT, and phospho-MARCK antibodies
were obtained from Cell Signaling Technology, whereas the GSK3 antibody
was purchased from Santa Cruz Biotechnology. Alexa Fluor 488 and 633 phal-
loidins were obtained from Invitrogen. SB216763 was from Sigma-Aldrich
(St. Louis, MO). LY294002 was obtained from ALEXIS Biochemicals. fMLP
was purchased from Sigma-Aldrich. PLCb2/b3-deficient and PI3Kg-deficient
mice have been previously described (Li et al., 2000). The triple KO mice
were generated by intercrossing PLCb2/b3-deficient and PI3Kg-deficient
mice. Recombinant PKCa and AKT1 proteins were from Cell Signaling
Technology, whereas the recombinant GSK3b protein was acquired from Sig-
nalChem (Richmond, Canada).
Neutrophil Preparation, Transfection, and Treatments
Mouse neutrophils were purified from bone marrow as previously described
using a discontinuous Percoll density gradient centrifugation (Zhang et al.,
2010). Their transient transfection was carried out using the human monocyte
nucleofection kit with the Amaxa system as previously described (Xu et al.,
2010). The cells were then cultured for 4 hr in the medium supplied with the
kit containing 10% FBS and 25 ng/ml recombinant GM-CSF. Before the
cells were used for experiments, they were incubated in HBSS containing
0.2% BSA on ice for 1 hr. Neutrophils may be pretreated with the vehicle
(HBSS plus 0.1% DMSO), LY294002 (30 mM), Ro31-8220 (10 mM), the AKT
inhibitor VIII (10 mM), SB216763 (5 mM), LiCl2 (20 mM) for 30 min or as noted
before chemoattractant stimulation as indicated in the figure legends. For
uniform stimulation, 1 mM fMLP or 100 ng/ml CXCL2 was used. For micropi-
pette, 10 mM fMLP or 1 mg/ml CXCL2 was loaded to the pipettes. Fibrinogen
(100 mg/ml) or poly-lysine (1 mg/ml) was used to coat glass coverslips.
In Vitro Chemotaxis Assay with Micropipette or a Dunn Chamber
For application of a chemoattractant gradient using a micropipette, an
Eppendorf Femotip was loaded with 10 mM fMLP, and an fMLP gradient was
maintained by applying a pressure to the micropipette using an Eppendorf1048 Developmental Cell 21, 1038–1050, December 13, 2011 ª2011FemotaJet microinjection system. The tip of the micropipette was placed
and attempted to be maintained at 50 mm from targeted cells. Time-lapse
image series were acquired at intervals noted in the figure legends. The
chemotaxis assay using a Dunn chamber was carried out as previously
described (Zicha et al., 1997) with some modifications as detailed in Xu et al.
(2010) and Zhang et al. (2010).
Neutrophil Staining
Neutrophils were placed onto the coverslips for 15 min before stimulation. In
some experiments, neutrophils were pretreated with LY294002, SB216763,
or LiCl for 30 min, and these inhibitors were present throughout the experi-
ment. The cells were then fixed with 4% paraformaldehyde and permeabilized
with 0.1% Triton in PBS. Mounted slides were observed under confocal
microscopy (Leica SP5). Staining of neutrophils with various antibodies was
carried out as previously described (Xu et al., 2010).
In Vitro Kinase Assay
For assaying phosphorylation of GSK3b by AKT1 and PKCa, GST-GSK3b
(80 ng; SignalChem) was incubated with GST-AKT1 (80 ng; Cell Signaling
Technology) in a buffer containing 25 mM Tris-HCl (pH 7.5), 5 mM b-glycero-
phosphate, 2 mM DTT, 0.1 mM Na3VO4, and 10 mMMgCl2 or PKCa (136 ng;
Cell Signaling Technology) in a buffer containing 0.5mg/ml phosphatidylserine,
50 mg/ml 1-stearoyl-2-linoleoyl-sn-glycerol, 50 mg/ml 1-oleoyl-2-acetyl-sn-
glycerol, 0.15% Triton X-100, 1 mM DTT, 2 mM CaCl2, and 20 mM MOPS
(pH 7.2). The kinase assays were initiated by adding 200 mM ATP and carried
out at 37C for 1 hr. For assaying phosphorylation of SSH2 or its mutants
by GSK3b, purified or immunoprecipitated substrates were incubated with
recombinant GSK3b (80 ng) in a buffer containing 25 mM Tris-HCl (pH 7.5),
5 mM b-glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3VO4, 10 mM
MgCl2), and [g-32P]ATP. After 30 min incubation at 30C, the reaction mixtures
were boiled in the SDS sample buffer and subjected to SDS-PAGE. Radioactive
samples were detected by a phosphoimager.
Generation of SSH2-Knockdown Neutrophils
SSH2-knockdown neutrophils were generated in mice that received the trans-
plantation of bone marrow cells infected with shSSH2-expressing viruses as
previously described (Zhang et al., 2010). Two independent Ssh2 shRNAs
were used. Their target sequences are: shShh2- 50-GCCGGACAGATTGAA
GATGAAT-30 and shSHH2-2- 50-CAGTGTTGGTGTGTTACAGAAA-30. Neutro-
phils were prepared from these mice 8 weeks after transplantation. The use
and care of animals were approved by the Institutional Animal Care and Use
Committee at Yale University.
FRET Imaging and Analysis of Live Neutrophils
Neutrophils transfected with the PKC FRET probe were stimulated with fMLP
from a micropipette. A series of time-lapse images were collected at 30 s time
intervals. To measure FRET, images were acquired for three sets of measure-
ments: (1) CFP fluorescence (425–445 nm excitation, 455 nm LP dichroic filter,
460–500 nm emission filter); (2) FRET fluorescence (425–445 nm excitation,
455 nmLP dichroic filter, 520–550 nm emission filter); and (3) YFP fluorescence
(490–510 nm excitation, 515 nm LP dichroic filter, 520–550 nm emission filter).
Cells of interest were selected for similar expression of YFP and CFP detected
by their respective filter sets and recorded using both FRET and CFP sets at
30 s intervals. Normalized FRET intensity values were calculated as the ratio
of CFP fluorescence to FRET fluorescence, which were further normalized to
the ratio of the image preceding fMLP stimulation as reference value set to 1.
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